Oculis Appoints Björn Tackenberg as Chief Scientific Officer
Position
Chief Scientific Officer
Company
Oculis Holding AG
LausanneBiotechnologyHealth CareTherapeuticsBiopharmaDescription
Oculis has announced the appointment of Björn Tackenberg, M.D., Ph.D., as its new Chief Scientific Officer. He will lead the company's global scientific strategy and expand its research portfolio, focusing on the development of Privosegtor.
Quick answer
Oculis Appoints Björn Tackenberg as Chief Scientific Officer (November 2, 2026). Oculis Holding AG is based in Lausanne, Vaud, Switzerland.
- Who is the new Chief Scientific Officer at Oculis Holding AG?
- Oculis Holding AG named Björn Tackenberg Chief Scientific Officer, announced November 2, 2026.
- What did Oculis Holding AG announce on November 2, 2026?
- Oculis has announced the appointment of Björn Tackenberg, M.D., Ph.D., as its new Chief Scientific Officer. He will lead the company's global scientific strategy and expand its research portfolio, focusing on the development of Privosegtor.
- Where did Björn Tackenberg work before joining Oculis Holding AG?
- Björn Tackenberg joins from Roche.
- What does Oculis Holding AG do?
- Oculis Holding AG is a global biopharmaceutical company purposefully driven to save sight and improve eye care.
- Where is Oculis Holding AG based?
- Oculis Holding AG is based in Lausanne, Vaud, Switzerland.
- Which similar companies made leadership changes around the same time?
- AlzeCure Pharma (November 1, 2026), AbbVie Inc. (November 2, 2026), Pfizer (November 3, 2026) and GemVax & KAEL (November 4, 2026) also announced leadership changes within 45 days of Oculis Holding AG.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Biopharma
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- AlzeCure Pharma Appoints Johan Sandin as Acting CEO and Pontus Forsell as Deputy CEO (November 1, 2026)
- AbbVie Director Resigns Following CEO Appointment at Align Technology (November 2, 2026)
- Pfizer Appoints Cecile Guegan as Chief Financial Officer (November 3, 2026)
- GemVax & KAEL Appoints Lee Jae-hong as Chief Medical Officer (November 4, 2026)
- Tempest Therapeutics names Stephanie Horn-Warnock CFO, Treasurer, & Corp Sec. (November 4, 2026)
- Peter Anastasiou Appointed as President and CEO of Harmony Biosciences (October 30, 2026)
Who to call at Oculis Holding AG, and when
A new leader at Oculis Holding AG brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Oculis Holding AG raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Oculis Holding AG, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Oculis Holding AG. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Oculis Holding AG changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Oculis Holding AG changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.